Prior authorization delays still drain clinician hours, derail care plans, and frustrate patients even as health plans roll out policy portals, FHIR APIs, and glossy dashboards that claim modernization, yet the promised speed rarely materializes because narrative rules do not compute themselves
Cervical cancer is on the brink of elimination in Australia, yet thousands of women still face stagnant survival when the diagnosis is uterine, ovarian, vulvar, vaginal, or placental, and that paradox now defines both the opportunity and the risk for a health system known for turning science into
Connecticut’s New Center of Gravity in Medical Debt Litigation Court dockets across Connecticut now tell an unmistakable story of medical debt collection shifting away from hospitals and toward physicians, dentists, imaging centers, ambulance companies, and other nonhospital providers, creating a n
Market Outlook: A One-Time Edit Reshapes the HAE Playbook A single gene edit cutting hereditary angioedema attacks by 87% is forcing the HAE market to rethink risk, price, and care delivery all at once, and the clock on first-in-class approval has started. The headline efficacy for Intellia
A quiet shift is already reshaping clinic visits as millions of people now ask chatbots for health answers before calling a nurse line, and the speed of that change keeps outpacing the slow, careful work of proving what is safe, effective, and fair. The Clinical AI Surge: Who’s Building It, Who’s Us
The integrity of medical services in Saskatchewan is entering a transformative phase as provincial authorities implement rigorous legislative measures to eliminate unauthorized practitioners from the healthcare system. This initiative stems from a growing demand for transparency and a
